These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9194768)

  • 1. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
    Malinow MR; Nieto FJ; Kruger WD; Duell PB; Hess DL; Gluckman RA; Block PC; Holzgang CR; Anderson PH; Seltzer D; Upson B; Lin QR
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1157-62. PubMed ID: 9194768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid.
    Kruger WD; Evans AA; Wang L; Malinow MR; Duell PB; Anderson PH; Block PC; Hess DL; Graf EE; Upson B
    Mol Genet Metab; 2000 May; 70(1):53-60. PubMed ID: 10833331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.
    Postiglione A; Milan G; Ruocco A; Gallotta G; Guiotto G; Di Minno G
    Gerontology; 2001; 47(6):324-9. PubMed ID: 11721146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
    Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
    Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
    Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
    Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.
    Fohr IP; Prinz-Langenohl R; Brönstrup A; Bohlmann AM; Nau H; Berthold HK; Pietrzik K
    Am J Clin Nutr; 2002 Feb; 75(2):275-82. PubMed ID: 11815318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
    Moat SJ; Ashfield-Watt PA; Powers HJ; Newcombe RG; McDowell IF
    Clin Chem; 2003 Feb; 49(2):295-302. PubMed ID: 12560354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.
    Nelen WL; Blom HJ; Thomas CM; Steegers EA; Boers GH; Eskes TK
    J Nutr; 1998 Aug; 128(8):1336-41. PubMed ID: 9687553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
    Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
    Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene.
    Schwartz SM; Siscovick DS; Malinow MR; Rosendaal FR; Beverly RK; Hess DL; Psaty BM; Longstreth WT; Koepsell TD; Raghunathan TE; Reitsma PH
    Circulation; 1997 Jul; 96(2):412-7. PubMed ID: 9244205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.
    Födinger M; Mannhalter C; Wölfl G; Pabinger I; Müller E; Schmid R; Hörl WH; Sunder-Plassmann G
    Kidney Int; 1997 Aug; 52(2):517-23. PubMed ID: 9264011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
    Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MTHFR 1298A-->C and MTHFR 677C-->T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kdiney graft recipients.
    Födinger M; Buchmayer H; Heinz G; Papagiannopoulos M; Kletzmayr J; Rasoul-Rockenschaub S; Hörl WH; Sunder-Plassmann G
    J Am Soc Nephrol; 2000 Oct; 11(10):1918-1925. PubMed ID: 11004224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
    Hanson NQ; Aras O; Yang F; Tsai MY
    Clin Chem; 2001 Apr; 47(4):661-6. PubMed ID: 11274015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
    Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
    J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease.
    de Jong SC; Stehouwer CD; van den Berg M; Kostense PJ; Alders D; Jakobs C; Pals G; Rauwerda JA
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1316-24. PubMed ID: 10323785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riboflavin as a determinant of plasma total homocysteine: effect modification by the methylenetetrahydrofolate reductase C677T polymorphism.
    Hustad S; Ueland PM; Vollset SE; Zhang Y; Bjørke-Monsen AL; Schneede J
    Clin Chem; 2000 Aug; 46(8 Pt 1):1065-71. PubMed ID: 10926884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.